CN Stock MarketDetailed Quotes

600276 Jiangsu Hengrui Pharmaceuticals

Watchlist
  • 49.18
  • -1.42-2.81%
Market Closed Oct 16 15:00 CST
313.72BMarket Cap57.79P/E (TTM)

Jiangsu Hengrui Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Jiangsu Hengrui Pharmaceuticals Q3 2024 Estimates Date

Currency：CNYOct 25, 2024

Estimate YoY
Revenue
6.74B
+15.26%
EPS
0.23
+19.05%
Analyst Rating
Strong Buy

Oct 16, 2024

Jiangsu Hengrui Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 6.667B--
Oct 25, 20242024/Q3-- / 6.737B--
Aug 22, 20242024/Q27.603B / 6.648B--
Apr 18, 20242024/Q15.998B / 6.071B--
--2023/Q45.806B / 6.199B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 6.667B--
Oct 25, 20242024/Q3-- / 6.737B--
Aug 22, 20242024/Q27.603B / 6.648B--
Apr 18, 20242024/Q15.998B / 6.071B--
--2023/Q45.806B / 6.199B--

Unlock Free Earnings Estimates

Jiangsu Hengrui Pharmaceuticals Earnings Reports

  • Jiangsu Hengrui Pharmaceuticals Semi-Annual Report for 2024

    Aug 21 12:00 ET

  • Jiangsu Hengrui Pharmaceuticals 2024 Interim Report Summary

    Aug 21 12:00 ET

  • Summary of Hengrui Pharmaceutical's 2023 Annual Report

    Apr 17 12:00 ET

  • Hengrui Pharmaceutical 2023 Annual Report

    Apr 17 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 16, 2024

    Strong Buy

    • Strong Buy

      84.62%

    • Buy

      11.54%

    • Hold

      3.85%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data